Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

NCT00510692 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Adenomatous Polyposis Coli
FAP

Interventions

DRUG: Eicosapentanoic Acid (EPA)
PROCEDURE: Endoscopy
PROCEDURE: Biopsies taken
DRUG: Placebo

Sponsor

S.L.A. Pharma AG